Total Payments
$806.10
2024 Payments
$151.81
Companies
16
Transactions
32
Medicare Patients
2,439
Medicare Billing
$426,871
Payment Breakdown by Category
Food & Beverage$582.59 (72.3%)
Education$223.51 (27.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $582.59 | 28 | 72.3% |
| Education | $223.51 | 4 | 27.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $228.71 | 8 | $0 (2022) |
| GENZYME CORPORATION | $118.39 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 | $0 (2023) |
| Genentech USA, Inc. | $70.67 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $41.70 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $32.55 | 3 | $0 (2019) |
| PFIZER INC. | $30.40 | 2 | $0 (2018) |
| TerSera Therapeutics LLC | $27.93 | 1 | $0 (2023) |
| Lilly USA, LLC | $27.17 | 2 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $21.86 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $151.81 | 3 | GENZYME CORPORATION ($97.21) |
| 2023 | $148.11 | 3 | SANOFI-AVENTIS U.S. LLC ($99.00) |
| 2022 | $55.92 | 2 | Janssen Biotech, Inc. ($34.08) |
| 2021 | $18.43 | 1 | Janssen Biotech, Inc. ($18.43) |
| 2020 | $21.86 | 1 | Dendreon Pharmaceuticals LLC ($21.86) |
| 2019 | $22.28 | 2 | Genentech USA, Inc. ($11.36) |
| 2018 | $264.73 | 12 | Janssen Biotech, Inc. ($152.45) |
| 2017 | $122.96 | 8 | Lilly USA, LLC ($27.17) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $97.21 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: BioOncology | ||||||
| 10/16/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 08/02/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Oncology | ||||||
| 02/06/2023 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 05/08/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: Oncology | ||||||
| 02/28/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Oncology | ||||||
| 03/11/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 01/28/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/28/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: BioOncology | ||||||
| 03/26/2019 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), KISQALI | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Oncology | ||||||
| 08/29/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 08/29/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Oncology | ||||||
| 07/30/2018 | Celgene Corporation | Revlimid (Drug) | Education | In-kind items and services | $10.51 | General |
| Category: Hematology / Oncology | ||||||
| 07/18/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Oncology | ||||||
| 05/29/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: INFLAMMATION | ||||||
| 05/15/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 05/08/2018 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Oncology | ||||||
| 04/18/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Oncology | ||||||
| 04/06/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 03/08/2018 | EMD Serono, Inc. | — | Education | In-kind items and services | $15.00 | General |
| 03/06/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: BioOncology | ||||||
| 12/05/2017 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 524 | 1,340 | $370,481 | $97,939 |
| 2022 | 5 | 617 | 1,597 | $453,847 | $122,496 |
| 2021 | 5 | 573 | 1,417 | $395,924 | $105,147 |
| 2020 | 7 | 725 | 1,638 | $240,261 | $101,288 |
Total Patients
2,439
Total Services
5,992
Medicare Billing
$426,871
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 247 | 675 | $189,072 | $46,736 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 429 | $121,516 | $30,147 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 51 | 51 | $18,269 | $6,845 | 37.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 79 | $12,173 | $4,512 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $9,278 | $3,748 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 34 | $11,755 | $3,694 | 31.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 25 | $4,575 | $1,151 | 25.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 15 | 21 | $3,843 | $1,105 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 240 | 777 | $224,263 | $55,112 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 425 | $122,680 | $30,721 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 73 | 115 | $39,815 | $13,190 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 46 | 46 | $16,928 | $6,348 | 37.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 109 | $16,140 | $6,070 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $16,192 | $5,852 | 36.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 45 | 63 | $11,529 | $3,093 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $6,300 | $2,111 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 225 | 700 | $201,446 | $49,131 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 436 | $125,884 | $31,278 | 24.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $14,328 | $5,198 | 36.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 69 | 85 | $13,005 | $4,987 | 38.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 34 | 34 | $12,500 | $4,686 | 37.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 27 | 35 | $12,217 | $4,046 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 48 | $7,108 | $2,712 | 38.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 17 | $5,917 | $1,904 | 32.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 20 | 23 | $3,519 | $1,205 | 34.2% |
About Dr. Bruce Mathey, MD
Dr. Bruce Mathey, MD is a Hematology & Oncology healthcare provider based in Mount Vernon, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366497463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Mathey, MD has received a total of $806.10 in payments from pharmaceutical and medical device companies, with $151.81 received in 2024. These payments were reported across 32 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($582.59).
As a Medicare-enrolled provider, Mathey has provided services to 2,439 Medicare beneficiaries, totaling 5,992 services with total Medicare billing of $426,871. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Mount Vernon, WA
- Active Since 05/24/2006
- Last Updated 03/20/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1366497463
Products in Payments
- IMBRUVICA (Drug) $134.66
- SARCLISA (Biological) $118.39
- ELITEK (Biological) $99.00
- DARZALEX (Biological) $94.05
- Lunsumio (Biological) $32.86
- Zoladex (Drug) $27.93
- CYRAMZA (Drug) $27.17
- TECENTRIQ (Biological) $26.64
- PROVENGE (Drug) $21.86
- IMFINZI (Biological) $21.84
- MYRISK (Device) $21.74
- Rubraca (Drug) $21.23
- NINLARO (Drug) $21.15
- IMFINZI (Drug) $19.86
- VARUBI (Drug) $18.09
- BOSULIF (Drug) $17.31
- INFLECTRA (Biological) $13.09
- Avastin (Biological) $11.17
- AFINITOR (Drug) $10.92
- KISQALI (Drug) $10.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mount Vernon
Jaideep Shenoi, Md, MD
Hematology & Oncology — Payments: $75,285
Hematology & Oncology $75,285
Kiarash Kojouri, M.d, M.D
Hematology & Oncology — Payments: $17,504
Hematology & Oncology $17,504
Dr. Junfeng Wang, M.d, M.D
Hematology & Oncology — Payments: $10,593
Hematology & Oncology $10,593
Hammad Shafqat, Md, MD
Hematology & Oncology — Payments: $1,747
Hematology & Oncology $1,747
Dr. Yagnesh Oza, M.d, M.D
Hematology & Oncology — Payments: $901.88
Hematology & Oncology $901.88
Dr. Geetha Naik, Md, MD
Hematology & Oncology — Payments: $13.86
Hematology & Oncology $13.86